systematic immune reaction, as measured by erythrocyte sedimentation rate (ESR) and C-reactive protein (CRP) (4). We investigate GNLY distribution and intracellular setting in peripheral blood lymphocytes of patients with OA. Objectives: Women with knee OA (17), and age and sex appropriated control (17) were tested. All of them signed informed consent before sampling of peripheral blood (PB). Methods: Medical history, clinical examination, X-ray and routine laboratory testing (ESR, CRP) were used for diagnosing OA. Peripheral blood mononuclear cells (PBMC) were isolated by gradient density centrifugation and used for multiple, simultaneous intracellular [total GNLY, 9 kDa GNLY, 15 kDa GNLY and Lysosomal-associated membrane protein-1 (LAMP-1)] and surface antigens (CD3 and CD56) detection by immunofluorescence. Data were analyzed by flow cytometry or confocal microscopy. Results: In OA and control samples the percentage of total GNLY+ cells and GNLY expressing NK and T cells did not significantly differ and correlate with ESR and CRP. The frequency of GNLY+ cells was always higher in natural killer (NK) then in T cells and 9 kDa GNLY dominated over 15 kDa GNLY. However, 9 kDa GNLY co-localized more with the marker of cell degranulation, LAMP-1 in polarized granules of OA patients when compared to the control or to the 15 kDa GNLY.
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Conclusions:
The increase in the expression of cytotoxic (9 kDa Background: Over the last years, the differentiation and activation of MDSC under tumor conditions has been studied extensively. Various tumor-derived factors have been identified in promoting the accumulation of this suppressive cell population. Recent findings determined the two alarmins S100A8 and S100A9 as important factors in the differentiation of MDSC during tumor conditions. However, little is known about the S100A8/A9 driven expansion and activation, as well as the relevance of these cells in autoimmune diseases such as rheumatoid arthritis. Objectives: We therefore analyzed the mechanisms involved in S100A8/A9 driven MDSC accumulation and their functional importance in a mouse model of rheumatoid arthritis. Methods: To investigate the effect of S100A8/A9 on MDSC differentiation, bone marrow cells from wild type (wt), S100A9 knockout (A9ko) and S100A9 transgenic (A9tg) mice were analyzed. Accumulation of MDSC and their phenotypical characterization was performed by FACS analysis and functional characterization including arginase activity, NO-and ROS-production and T cell proliferation assays. The role of S100A8/A9 and MDSC in arthritis was investigated using the collagen-induced arthritis (CIA) mouse model. Accumulation of MDSC in different organs was analyzed by FACS and systemic S100A8/A9 levels were measured by ELISA. Ex vivo functional analysis of purified MDSC was performed to assess the potential of these MDSC to inhibit T cell responses. Results: Our in vitro studies reveal that, in the presence of S100A8, myeloid progenitor cells differentiate to immature cells that phenotypically as well as functionally resemble MDSC. These cells are characterized by co-expression and up-regulation of arginase activity, NO-and ROS-production, and exhibit strong suppressive effects on the proliferation of both CD4-and CD8-positive T cells. Furthermore, accumulation of MDSC by extracellular S100A8 was found to be mediated via the Toll-like receptor 4 signaling pathway. In addition, lack of intracellular S100A8/A9 results in a decreased number of MDSC as well as a reduced suppressive activity of these cells, implying a dual role of these proteins for MDSC differentiation and function. Investigating the role of S100A8/A9 and MDSC in a mouse model of CIA, a clear correlation between disease scores, MDSC numbers and systemic S100A8/A9 levels was observed. Furthermore, disease activity was reduced in wt and A9tg mice compared to A9ko mice and was in line with an increased accumulation of MDSC in the lymph nodes. Next to an enhanced suppressive activity of MDSC isolated from lymph nodes of wt and A9tg mice, these MDSC promoted the accumulation of regulatory T cells (Treg) whilst suppressing the differentiation of TH17 cells. In contrast, MDSC isolated from lymph nodes of A9ko mice had no effect on Treg differentiation and did not inhibit TH17 emergence. Conclusions: Our in vitro results clearly show a S100A8/A9 dependent accumulation of cells that phenotypically as well as functionally resemble MDSC also under non-tumor conditions. In vivo data strongly support the importance of these findings. By influencing MDSC accumulation and function, S100A8/A9 is critically involved in regulating the disease outcome in rheumatoid arthritis, implying an important role of S100A8/A9 derived MDSC in regulating immune reactions during autoimmune diseases. Background: There is growing evidence that nervous and immune system communicate with each other through soluble mediators.
1 Immune cells such as neutrophils express muscarinic acetylcholine receptors (mAChR), which are neuroimmune receptors and highly prevalent in the nervous system.
2 Aberrant neutrophil functioning plays an important role in various autoimmune diseases. Dysregulation of neutrophil immune responses such as oxidative burst and migration is one of the key mechanisms leading to tissue damage in autoimmune diseases.
3 However, the impact of mAChR activation on neutrophils remains contradictory. Objectives: We aimed to determine effects of muscarinic receptor activation on development and functions of neutrophils. Methods: Neutrophils were isolated from peripheral blood of healthy donors by dextran sedimentation. After one hour in the absence or presence of the natural ligand acetylcholine (Ach) (10nM-100μM) or the muscarinic agonist oxotremorine-m (oxo-m) (10nM-100μM), neutrophil respiratory burst was analyzed by dihydrorhodamine (DHR) flow cytometry assay and migration assessed by transwell assay in response to N-formylmethionyl-leucyl-phenylalanine (fMLP). Cells that migrated were quantified by flow cytometry. To analyze the effects mAChR activation on the development of neutrophils, HL-60 cells were incubated in the presence of DMSO (1%), oxo-m (100μM) or DMSO plus oxo-m. After 6 days, cells were harvested and expression of maturation markers (CD15, CD63 and CD16) as well as mAChR (M1-M5) were measured by flow cytometry. Results: We observed no effects of mAChR activation on the respiratory burst of neutrophils. However, both ACh and oxo-m inhibited neutrophil migration in a dose-dependent manner, but with peculiar differences. By increasing acetylcholine concentrations, we observed a reduction of neutrophil migration in a directly proportional manner. On the other hand, while the lowest dose (10nM) of oxo-m inhibited migration most effectively, the increase of oxo-m showed inversely proportional effects on neutrophil migration. Thus, we aimed to investigate, if the highest dose of oxo-m has a different effect on neutrophils ontogeny. In agreement with the results obtained with neutrophils, the incubation of HL-60 cells with the highest dose of oxo-m showed no effect on oxidative burst and migration and induced no changes in the expression of mAChRs (M1-M5), CD16 and CD63 in HL-60 cells. However, we observed that it resulted in significantly increased surface levels of the neutrophilic lineage marker CD15. Conclusions: Our data indicate a differential activation of mAChR affecting different steps of neutrophil ontogeny. Considering this finding, abnormalities in the activation of muscarinic receptors as have been observed in autoimmune diseases might contribute to neutrophil dysfunction and need further investigation. Background: It is increasingly recognized that part of the pathology in osteoarthri-
